BCAX - Bicara Therapeutics Common Stock - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BCAX is currently covered by 5 analysts with an average price target of $35.25. This is a potential upside of $15.6 (55.49%) from yesterday's end of day stock price of $22.67.

Bicara Therapeutics Common Stock's activity chart (see below) currently has 18 price targets and 26 ratings on display. The stock rating distribution of BCAX is 72.73% BUY and 27.27% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.08% with an average time for these price targets to be met of 49.92 days.

Highest price target for BCAX is $48, Lowest price target is $16, average price target is $35.25.

Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 12-Aug-2026. First documented stock forecast 08-Oct-2024.

Best performing analysts who are covering BCAX - Bicara Therapeutics Common Stock:

David Nierengarten Robert Burns Stephen Willey Soumit Roy

Currently out of the existing stock ratings of BCAX, 8 are a BUY (72.73%), 3 are a HOLD (27.27%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 05-Feb-2025

$33

$10.19 (44.67%)

$30

1 months 4 days ago
(12-Aug-2026)

2/5 (40%)

$8.37 (33.98%)

137

Hold Since 10-Nov-2025

$23

$0.19 (0.83%)

$16

1 months 4 days ago
(12-Aug-2026)

1/4 (25%)

$-1.63 (-6.62%)

30

Buy Since 06-Dec-2024

$42

$15.13 (56.31%)

$40

5 months 16 days ago
(31-Mar-2026)

0/6 (0%)

$22.11 (111.16%)

Buy Since 08-Oct-2024

$48

$21.13 (78.64%)

$48

10 months 26 days ago
(21-Oct-2025)

0/5 (0%)

$30.94 (181.36%)

Buy Since 09-Sep-2025

$22

$-4.87 (-18.12%)

1 years 7 days ago
(09-Sep-2025)

1/1 (100%)

$9.54 (76.57%)

216

Show more analysts

Please expand the browser size to see the chart

What is BCAX (Bicara Therapeutics Common Stock) average time for price targets to be met?

On average it took 50 days for the stock forecasts to be reached, with an average price target met ratio of 22.08%.

Which analyst most recently updated their price target on BCAX (Bicara Therapeutics Common Stock)?

David Nierengarten

Which analyst has the most public recommendations on BCAX (Bicara Therapeutics Common Stock)?

David Nierengarten works at WEDBUSH and has 16 price targets and 11 ratings on BCAX

Which analyst is the currently most bullish on BCAX (Bicara Therapeutics Common Stock)?

Stephen Willey with the highest potential upside of $25.19

Which analyst is the currently most reserved on BCAX (Bicara Therapeutics Common Stock)?

Eva Fortea Verdejo with the lowest potential downside of -$10.87

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?